FrançaisAre analysts right about Bath & Body Works, Inc. (BBWI)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Bath & Body Works, Inc., we replayed every analyst price target of the past 12 months and measured the real outcome: 9% were profitable, average return -16% (132 calls). At 3 months: -1% average return (36% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Telsey Advisory Group | 38 | 8% | -18% |
| Morgan Stanley | 10 | 10% | -19% |
| Raymond James | 10 | 20% | +0% |
| Deutsche Bank | 9 | 0% | -14% |
| Baird | 8 | 0% | -16% |
Valuation
Is Bath & Body Works, Inc. overvalued, and is it a good time to buy Bath & Body Works, Inc. right now? If you're wondering, here's a recap to make up your own mind: Bath & Body Works, Inc.'s valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Bath & Body Works, Inc. | Sector median (Consumer Discretionary) |
|---|---|---|
| P/E | 5.0 | 19.9 |
| Forward P/E | 6.6 | 14.4 |
| Net margin | 11% | 9% |
👉 Bath & Body Works, Inc. trades below its sector median (5.0 vs 19.9) — potentially undervalued, or lower expected growth.
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : Bath & Body Works, Inc. pays about $0.80/share/yr → 3.58% yield. what is this?
Frequently asked questions
Is Bath & Body Works, Inc. a buy right now?
The analyst consensus on Bath & Body Works, Inc. (BBWI) is "Hold" (16 bullish, 1 bearish calls over 12 months). This is not advice: historically, 9% of their targets on this stock turned out profitable over 1 year.
What is Bath & Body Works, Inc.'s price target?
The median 12-month price target is $23.00 (+23% vs $18.65), ranging from $19.00 to $26.00 (9 analysts).
Are analysts accurate on Bath & Body Works, Inc.?
Over 1 year, 9% of analyst targets on Bath & Body Works, Inc. were profitable, for an average return of -16% (across 132 timestamped calls). This is JPI Invest's accuracy metric.
What is the Bath & Body Works, Inc. stock forecast?
Analysts target a median of $23.00 within 12 months, i.e. +23% vs the current price. The most bullish targets $26.00, the most cautious $19.00.
What is the Bath & Body Works, Inc. stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $23.00, +23%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (9%), and the stock's past trajectory.
Is Bath & Body Works, Inc. overvalued?
Its P/E is 5.0, forward P/E 6.6. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Bath & Body Works, Inc. →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.